254 related articles for article (PubMed ID: 34414880)
21. Anaphylaxis is a rare reaction in COVID-19 vaccination.
Bellomo RG; Gallenga CE; Caraffa A; Tetè G; Ronconi G; Conti P
J Biol Regul Homeost Agents; 2021; 35(3):839-842. PubMed ID: 34105336
[TBL] [Abstract][Full Text] [Related]
22. Polyarthralgia and Myalgia Syndrome after ChAdOx1 nCOV-19 Vaccination.
Hyun H; Song JY; Seong H; Yoon JG; Noh JY; Cheong HJ; Kim WJ
J Korean Med Sci; 2021 Aug; 36(34):e245. PubMed ID: 34463066
[TBL] [Abstract][Full Text] [Related]
23. Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines.
Moghimi SM
Mol Ther; 2021 Mar; 29(3):898-900. PubMed ID: 33571463
[No Abstract] [Full Text] [Related]
24. Transmission dynamics and control of two epidemic waves of SARS-CoV-2 in South Korea.
Ryu S; Ali ST; Noh E; Kim D; Lau EHY; Cowling BJ
BMC Infect Dis; 2021 May; 21(1):485. PubMed ID: 34039296
[TBL] [Abstract][Full Text] [Related]
25. COVID-19 in South Korea: epidemiological and spatiotemporal patterns of the spread and the role of aggressive diagnostic tests in the early phase.
Lee W; Hwang SS; Song I; Park C; Kim H; Song IK; Choi HM; Prifti K; Kwon Y; Kim J; Oh S; Yang J; Cha M; Kim Y; Bell ML; Kim H
Int J Epidemiol; 2020 Aug; 49(4):1106-1116. PubMed ID: 32754756
[TBL] [Abstract][Full Text] [Related]
26. Adverse Events in Healthcare Workers after the First Dose of ChAdOx1 nCoV-19 or BNT162b2 mRNA COVID-19 Vaccination: a Single Center Experience.
Kim SH; Wi YM; Yun SY; Ryu JS; Shin JM; Lee EH; Seo KH; Lee SH; Peck KR
J Korean Med Sci; 2021 Apr; 36(14):e107. PubMed ID: 33847085
[TBL] [Abstract][Full Text] [Related]
27. Dynamics of the COVID-19 epidemic in the post-vaccination period in Korea: a rapid assessment.
Min KD; Tak S
Epidemiol Health; 2021; 43():e2021040. PubMed ID: 34082498
[TBL] [Abstract][Full Text] [Related]
28. Coronavirus Disease Exposure and Spread from Nightclubs, South Korea.
Kang CR; Lee JY; Park Y; Huh IS; Ham HJ; Han JK; Kim JI; Na BJ;
Emerg Infect Dis; 2020 Oct; 26(10):2499-2501. PubMed ID: 32633713
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of COVID-19 epidemic outbreak caused by temporal contact-increase in South Korea.
Kim S; Jeong YD; Byun JH; Cho G; Park A; Jung JH; Roh Y; Choi S; Muhammad IM; Jung IH
Int J Infect Dis; 2020 Jul; 96():454-457. PubMed ID: 32417246
[TBL] [Abstract][Full Text] [Related]
30. Conversations and Medical News Frames on Twitter: Infodemiological Study on COVID-19 in South Korea.
Park HW; Park S; Chong M
J Med Internet Res; 2020 May; 22(5):e18897. PubMed ID: 32325426
[TBL] [Abstract][Full Text] [Related]
31. How many published cases of serious adverse events after yellow fever vaccination meet Brighton Collaboration diagnostic criteria?
Thomas RE; Spragins W; Lorenzetti DL
Vaccine; 2013 Dec; 31(52):6201-9. PubMed ID: 24436960
[TBL] [Abstract][Full Text] [Related]
32. The Serial Interval of COVID-19 in Korea: 1,567 Pairs of Symptomatic Cases from Contact Tracing.
Hong K; Yum S; Kim J; Chun BC
J Korean Med Sci; 2020 Dec; 35(50):e435. PubMed ID: 33372427
[TBL] [Abstract][Full Text] [Related]
33. Intraoperative anaphylaxis to neuromuscular blocking agents: the incidence over 9 years at two tertiary hospitals in South Korea: A retrospective observational study.
Cho YJ; Ju JW; Sim H; Lee JH; Hong DM; Kim TK; Min JJ; Song WJ; Kang HR; Cho SH; Jeon Y
Eur J Anaesthesiol; 2016 May; 33(5):368-78. PubMed ID: 26575006
[TBL] [Abstract][Full Text] [Related]
34. Age-stratified analysis of SARS-CoV-2 infection and case fatality rate in China, Italy, and South Korea.
Liu JQ; Xu JW; Sun CY; Wang JN; Wang XT; Chen X; Gao SL
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12575-12578. PubMed ID: 33336777
[TBL] [Abstract][Full Text] [Related]
35. The proportion of COVID-19 cases that are asymptomatic in South Korea: Comment on Nishiura et al.
Workman J
Int J Infect Dis; 2020 Jul; 96():398. PubMed ID: 32417245
[TBL] [Abstract][Full Text] [Related]
36. Clinical Characteristics and Viral RNA Detection in Children With Coronavirus Disease 2019 in the Republic of Korea.
Han MS; Choi EH; Chang SH; Jin BL; Lee EJ; Kim BN; Kim MK; Doo K; Seo JH; Kim YJ; Kim YJ; Park JY; Suh SB; Lee H; Cho EY; Kim DH; Kim JM; Kim HY; Park SE; Lee JK; Jo DS; Cho SM; Choi JH; Jo KJ; Choe YJ; Kim KH; Kim JH
JAMA Pediatr; 2021 Jan; 175(1):73-80. PubMed ID: 32857112
[TBL] [Abstract][Full Text] [Related]
37. [COVID-19 vaccines increase the risk of anaphylaxis].
Alnæs M; Storaas T; Sørensen M; Stylianou E; Tøndell A
Tidsskr Nor Laegeforen; 2021 Mar; 141(4):. PubMed ID: 33685103
[No Abstract] [Full Text] [Related]
38. Immunization practices and risk of anaphylaxis: a current update, comprehensive of COVID-19 vaccination data.
Arcolaci A; Bronte V; Zanoni G
Curr Opin Allergy Clin Immunol; 2021 Oct; 21(5):418-425. PubMed ID: 34269740
[TBL] [Abstract][Full Text] [Related]
39. Lessons Learned From Cases of COVID-19 Infection in South Korea.
Kang YJ
Disaster Med Public Health Prep; 2020 Dec; 14(6):818-825. PubMed ID: 32378503
[TBL] [Abstract][Full Text] [Related]
40. The Importance of a Timely Second Dose of the 2021 COVID-19 mRNA Vaccine Depends on the Protection Afforded by a First Dose and Subsequent Risk of Anaphylaxis.
Shaker M; Phillips E; Blumenthal KG; Abrams EM; Banerji A; Oppenheimer J; Vander Leek TK; Mack DP; Wickner PG; Singer AG; Khan DA; Greenhawt M
J Allergy Clin Immunol Pract; 2021 Jul; 9(7):2556-2561. PubMed ID: 33892171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
